Greiner Bio-One Americas, operating under the slogan "Making a difference.", is a prominent player in the biotechnology industry, known for its commitment to excellence in the development and distribution of high-quality plastic laboratory products. The company serves as a technology partner to a wide range of institutions including hospitals, laboratories, universities, and the diagnostic, pharmaceutical, and biotechnology sectors.
The company is structured into two main business divisions: Preanalytics and BioScience. The Preanalytics division, based in Austria, focuses on innovating collection systems for medical and veterinary samples. By integrating Greiner eHealth Technologies, it enhances efficiency and safety in preanalytical processes. The BioScience division, located in Germany, excels in products for cell and tissue culture analysis, cryopreservation, and high-throughput screening.
Founded in 1868, Greiner Bio-One has expanded its global presence with facilities in 28 locations across 22 countries. It is part of Greiner AG and employs 2,540 individuals. Despite its rich history, the company continues to innovate and evolve, although it has not recently disclosed any new investments. Investors may view it as a stable entity with a strong legacy in advancing laboratory technologies.